Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Hyphen BioMed

Hyphen BioMed
1999 FOUNDED
M&A STATUS
71-80 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Operator of a technical and innovative, scientific company intended to propose a full line of diagnostic and research reagents to be distributed worldwide. The company's diagnostic and research reagents are available worldwide, through a network of specialised distributors, or directly from the company and its laboratories are equipped with analytical instruments and with highly performing manufacturing machines and quality control analyzers enabling the company to conceive, manufacture, market and develop research and biomedical in vitro diagnostic reagents for the exploration of Thrombosis, Haemostasis and Auto-Immunity. It owns a complete range of analytical equipment for immunological, clotting and chromogenic methods, cell culture, production of recombinant proteins, engineering and purification of proteins from plasma or biological extracts.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Chemicals and Gases
Biotechnology
Drug Discovery
Parent Company
Primary Office
  • ZAC Neuville-Universit√©
  • 155 Rue d'Eragny
  • 95000 Neuville-sur-Oise
  • France

Hyphen BioMed Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Hyphen BioMed‘s full profile, request access.

Request full access to PitchBook

Hyphen BioMed Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Hyphen BioMed‘s full profile, request access.

Request full access to PitchBook

Hyphen BioMed Executive Team (2)

Name Title Board
Seat
Contact
Info
Anne Marie Vissac Co-Founder, Technical Director & Managing Director
Jean Amiral Ph.D Co-Founder, President & Scientific and Research Director